热线电话:+86-0000-96877

banner2
诚信为本,市场永远在变,诚信永远不变

威尼斯会所提钱,水城威尼斯在哪里


 

 Introduction to PoolingMed Co., Ltd.

PoolingMed Co., Ltd. is the company in China which focuses on providing medical research consulting and technical services for clinical doctors. Its services include research project design & implementation, data processing & analysis, and research reports summarization. 

We have employed a professional team led by full-time scientists who used to work in the world-renowned institutions. Our technical team is especially expert in eight areas of research, including medical cell biology, animal disease models, medical molecular biology, medical electrophysiology, medical nano material, medical genetics and bioinformatics, pathology and medical imaging, drug research and development. Respectively, eight research centres are also established upon those areas.

Aside from strengths of our team, the strategic cooperation relationships with more than 300 laboratories around the nation can meet the demands on over 90% medical researches. 

To date, we have provided high-quality services to over 5000 medical research teams, and have helped a great number of our objective customers with a continual development in their scientific careers. 

When we provide services to our customers, we always stick to our company’s vision of ‘To lead medical research and improve human health’, and our mission of “To make medical research easier’. During the long time operation of our company, we have become the first one to raise the concept of Scientific Research 5.0 and have been practicing it in our daily activities. In addition, we have also invented a useful tool encompassing six fundamental ways to help propose new ideas for scientific researches.

 

                                                  普略医学集团


        普略医学集团专注肿瘤等各种退行性疾病的医学研究和相关产品和技术研发,是国内较早成立的高端医学科学集团。
        通过多年运作,普略医学自建、共建、参股和战略合作了100多个拥有各种高精尖仪器和技术的研究和研发实验室,整合形成了医学细胞生物学、疾病动物模型、医学分子生物学、医学电生理学、医用纳米材料、医学遗传学和组学、病理学和医学影像学、药物研究等八大医学研究和研发平台,能满足绝大部分医学研究和研发需求。
        普略医学主要专注研究肿瘤、神经退行性疾病、心脑血管病等与人体老化密切相关的重大疾病研究,研发和临床推广诊疗此类重大疾病的新产品和新技术。
        在长期持续的医学研究和研发过程中,公司培养了执行力强的研究、研发和运营团队;科研团队总结出了医学科研创新的六个基本方法。目前每年有医学研究或研发项目300多项在研,合作单位包括北京协和、华西医院、解放军总医院、瑞金医院、华山医院、中山医院、浙一医院、浙二医院、邵逸夫医院、江苏省人民医院、鼓楼医院、中大医院等国内顶级研究型三甲医院,以及北京大学、清华大学、中国科学院、浙江大学、复旦大学、上海交通大学、四川大学、中山大学等国内顶级院校。
        普略医学控股百替生物、博医生物、晟恩医药和百畅生物等子公司,在北京、南京等地设立普略医学研究院。公司总部设在杭州,在北京、上海、南京和成都等医学中心城市设有全资子公司。
        公司以“引领医学科研,提升国人健康”、“攻克重大疾病”为愿景和使命,运用“科研5.0”新理念,引领医学科究新风尚。普略医学的战略目标是成为中国的安进。